for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Walgreens Boots Alliance Inc

WBA.O

現在値

47.10USD

変化

-0.02(-0.04%)

出来高

4,839,487

本日のレンジ

46.66

 - 

47.35

52週レンジ

33.36

 - 

57.05

∙ 約20分前の相場を表示しています。

適時開示

Walgreens Boots Alliance Announces Transformational Consumer-Centric Healthcare Strategy To Fuel Long-Term Growth

Oct 14 (Reuters) - WALGREENS BOOTS ALLIANCE::WALGREENS BOOTS ALLIANCE ANNOUNCES TRANSFORMATIONAL CONSUMER-CENTRIC HEALTHCARE STRATEGY TO FUEL LONG-TERM GROWTH.WALGREENS - TRANSFORMATIONAL COST MANAGEMENT PROGRAM DELIVERED IN EXCESS OF $2 BILLION IN ANNUAL COST SAVINGS BY THE END OF FISCAL YEAR 2021.WALGREENS - RAISING SAVINGS GOAL UNDER TRANSFORMATIONAL COST MANAGEMENT PROGRAM TO $3.3 BILLION BY FISCAL YEAR 2024.WALGREENS - BEYOND FISCAL 2024, CO'S LONG-TERM GROWTH ALGORITHM LEADS TO ADJUSTED. EPS GROWTH OF 11 TO 13 PERCENT.WALGREENS - CO’S NEW WALGREENS HEALTH SEGMENT WILL BE IN INVESTMENT MODE, WHICH SHOULD DRIVE SIGNIFICANT FUTURE REVENUE & ADJUSTED. OPERATING INCOME GROWTH.WALGREENS - CO INTRODUCED FISCAL 2022 GUIDANCE OF FLAT GROWTH IN ADJUSTED EPS AT CONSTANT CURRENCY RATES.WALGREENS - CO ANTICIPATES CORE GROWTH OF 4% OFFSET BY INVESTMENTS IN WALGREENS HEALTH.WALGREENS - OVER NEXT 3 YEARS, EXPECTS ANNUAL ADJUSTED. EPS CORE GROWTH OF AROUND 4%, WITH FLAT GROWTH IN FISCAL 2022 & ACCELERATION EACH YEAR THEREAFTER.WALGREENS - CO HAS AN OPTION TO ACQUIRE REMAINING EQUITY INTERESTS IN CARECENTRIXIN THE FUTURE.WALGREENS - CARECENTRIX’ OTHER EQUITY HOLDERS WILL HAVE OPTION TO REQUIRE CO TO PURCHASE REMAINING EQUITY INTERESTS, UNDER AGREEMENT. ((Reuters.Briefs@thomsonreuters.com;)).

Kinnevik Commits To Sell Minimum $340 Million Interest In VillageMD

Oct 14 (Reuters) - Kinnevik AB <KINVb.ST>::REG-VILLAGEMD AND WALGREENS ENTER INTO TRANSFORMATIONAL TRANSACTION IN WHICH KINNEVIK HAS COMMITTED TO SELL A MINIMUM USD 340 MILLION INTEREST IN VILLAGEMD.AFTER TRANSACTION, KINNEVIK EXPECTS TO RETAIN AN APPROXIMATE 4 PERCENT STAKE IN VILLAGEMD.

Walgreens Boots Alliance - Q4 Earnings Per Share $0.41

Oct 14 (Reuters) - Walgreens Boots Alliance Inc <WBA.O>::Q4 EARNINGS PER SHARE $0.41 FROM CONTINUING OPERATIONS.Q4 EARNINGS PER SHARE ESTIMATE $1.01 -- REFINITIV IBES DATA.Q4 ADJUSTED EARNINGS PER SHARE $1.17 FROM CONTINUING OPERATIONS.WALGREENS - Q4 SALES FROM CONTINUING OPERATIONS INCREASED 12.8 PERCENT YEAR-OVER-YEAR, TO $34.3 BILLION, UP 11.8 PERCENT ON A CONSTANT CURRENCY BASIS.WALGREENS - UNITED STATES SEGMENT HAD Q4 SALES OF $28.8 BILLION, AN INCREASE OF 6.6 PERCENT FROM YEAR-AGO QUARTER.WALGREENS - INTERNATIONAL SEGMENT HAD Q4 SALES OF $5.5 BILLION, UP 61.8% FROM YEAR-AGO QUARTER.WALGREENS - QTRLY COMPARABLE SALES FOR UNITED STATES SEGMENT INCREASED 8.1 PERCENT FROM YEAR-AGO QUARTER.WALGREENS - WALGREENS SURPASSED COVID-19 VACCINATION GOAL, PROVIDING 13.5 MILLION VACCINATIONS IN QUARTER AND 34.6 MILLION IN FISCAL 2021.Q4 REVENUE VIEW $33.30 BILLION -- REFINITIV IBES DATA.

Walgreens Boots Alliance Makes $5.2 Billion Investment In VillageMD

Oct 14 (Reuters) - WALGREENS::WALGREENS - INVESTMENT INCREASES OWNERSHIP STAKE IN VILLAGEMD TO 63%.WALGREENS BOOTS ALLIANCE MAKES $5.2 BILLION INVESTMENT IN VILLAGEMD TO DELIVER VALUE-BASED PRIMARY CARE TO COMMUNITIES ACROSS AMERICA.WALGREENS - INVESTMENT INCREASES NUMBER OF CO-LOCATED PRIMARY CARE PRACTICES TO OVER 600 IN MORE THAN 30 U.S. MARKETS BY 2025 & 1,000 BY 2027.WALGREENS - VILLAGEMD REMAINS A STANDALONE CO, WITH ITS OWN BOARD AND MANAGEMENT, VILLAGEMD PLANS TO CONDUCT AN IPO IN 2022. ((Reuters.Briefs@thomsonreuters.com;)).

Walgreens Boots Alliance Makes Majority Investment In Shields Health Solutions

Sept 21 (Reuters) - Walgreens Boots Alliance: :WALGREENS BOOTS ALLIANCE MAKES MAJORITY INVESTMENT IN SHIELDS HEALTH SOLUTIONS.WALGREENS BOOTS - SHIELDS’ OTHER EQUITY HOLDERS WILL ALSO HAVE OPTION TO REQUIRE CO TO PURCHASE REMAINING EQUITY INTERESTS.WALGREENS BOOTS - NEW INVESTMENT OF ABOUT $970 MILLION GIVES CO ABOUT 71% OWNERSHIP OF SHIELDS, WITH OPTION TO BUY REMAINING EQUITY INTERESTS IN FUTURE.WALGREENS BOOTS - FOLLOWING COMPLETION OF INVESTMENT, SHIELDS WILL BE MANAGED UNDER CURRENT EXECUTIVE LEADERSHIP AND AS DISTINCT BRAND AND ENTITY. ((Reuters.Briefs@thomsonreuters.com;)).

Walgreens' COVID-19 Test Registration System Exposed Patient Data- Recode

Sept 13 (Reuters) - :WALGREENS’ COVID-19 TEST REGISTRATION SYSTEM EXPOSED PATIENT DATA- RECODE.WALGREENS' DATA EXPOSURE POTENTIALLY AFFECTS MILLIONS OF PEOPLE WHO USED WALGREENS’ COVID-19 TESTING SERVICES- RECODE. ((Reuters.Briefs@thomsonreuters.com;)).

Walgreens To Raise Starting Hourly Wage To $15

Aug 31 (Reuters) - Walgreens Boots Alliance Inc <WBA.O>::WALGREENS INCREASES STARTING WAGE FOR HOURLY TEAM MEMBERS.WALGREENS - WALGREENS WILL INCREASE STARTING HOURLY WAGE FOR ALL TEAM MEMBERS TO $15.00 AN HOUR.WALGREENS - TOTAL INVESTMENT TO SUPPORT STARTING WAGE INCREASE IS ANTICIPATED TO BE APPROXIMATELY $450 MILLION OVER NEXT THREE YEARS.WALGREENS - HOURLY WAGE INCREASE TAKING EFFECT IN PHASES BEGINNING IN OCTOBER AND EXPECTED TO BE FULLY IMPLEMENTED BY NOVEMBER 1, 2022.

Lemonaid Health Launches Services In UK

Aug 3 (Reuters) - Lemonaid Health::LEMONAID HEALTH SAYS IS EXPANDING INTERNATIONALLY WITH LAUNCH OF SERVICES IN UK IN PARTNERSHIP WITH BOOTS UK.

U.S. CPSC Says Academy Sports + Outdoors Recalls Ozone 500 Girls' And Boys' Elevate 24-Inch Bicycles Due To Fall And Injury Hazards

July 14 (Reuters) - U.S. CPSC::U.S. CPSC SAYS ACADEMY SPORTS + OUTDOORS RECALLS OZONE 500 GIRLS' AND BOYS' ELEVATE 24-INCH BICYCLES DUE TO FALL AND INJURY HAZARDS.U.S. CPSC SAYS ACADEMY SPORTS + OUTDOORS HAS RECEIVED ONE REPORT OF INJURY INVOLVING OZONE 500 GIRLS’ AND BOYS’ ELEVATE 24-INCH BICYCLES.U.S. CPSC SAYS WALGREENS RECALLS DISNEY BABY WINNIE POOH RATTLE SETS DUE TO CHOKING HAZARD.U.S. CPSC SAYS WALGREENS HAS RECEIVED 8 REPORTS OF THE FEET ON THE WINNIE THE POOH RATTLE DETACHING; NO INJURIES HAVE BEEN REPORTED.

Walgreens Boots Alliance Reports Q3 Earnings Per Share Of $1.38

July 1 (Reuters) - Walgreens Boots Alliance Inc <WBA.O>::WALGREENS BOOTS ALLIANCE FISCAL 2021 THIRD QUARTER RESULTS EXCEED EXPECTATIONS.Q3 ADJUSTED EARNINGS PER SHARE $1.38 FROM CONTINUING OPERATIONS.Q3 EARNINGS PER SHARE $1.27 FROM CONTINUING OPERATIONS.Q3 EARNINGS PER SHARE $1.38.Q3 EARNINGS PER SHARE ESTIMATE $1.17 -- REFINITIV IBES DATA.WALGREENS - COMPANY RAISES FULL-YEAR GUIDANCE TO AROUND 10 PERCENT EPS GROWTH.WALGREENS - HAS ADMINISTERED MORE THAN 25 MILLION COVID-19 VACCINATIONS TO DATE.WALGREENS - QTRLY SALES FROM CONTINUING OPERATIONS INCREASED 12.1% TO $34.0 BILLION, UP 10.4% ON A CONSTANT CURRENCY BASIS.Q3 REVENUE VIEW $33.76 BILLION -- REFINITIV IBES DATA.WALGREENS - ON TRACK TO DELIVER IN EXCESS OF $2 BILLION IN ANNUAL COST SAVINGS BY FISCAL 2022.WALGREENS - QTRLY UNITED STATES COMPARABLE SALES INCREASED 6.4 PERCENT FROM YEAR-AGO QUARTER.WALGREENS - QTRLY BOOTS UK COMPARABLE PHARMACY SALES INCREASED 3.7 PERCENT COMPARED WITH YEAR-AGO QUARTER.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up